Ethical Compliance
STRIDES PHARMA SCI
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
medium
Revenue
0.7%
Debt
37%
Liquidity
2.9%
Revenue
Debt
Liquidity
0.7%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Income | ₹9.27 |
| Other Operating Revenue | ₹160.10 |
| Sale of Pharmaceuticals Products & Services | ₹3,829.23 |
| Sale of Services | ₹61.79 |
Questionable
INR Crores
| Investment Gain | ₹0.79 |
Non Compliant
INR Crores
| Interest Income | ₹29.64 |
INR Crores
| Revenue from Questionable Sources: | ₹0.79 |
| Revenue from Non Compliant Sources: | ₹29.64 |
| Total: | ₹30.43 |
| Total Revenue: | ₹4,090.83 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹30.43
₹4,090.83
= 0.7%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
